3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Myelodysplastic Syndromes
15
Hematologic Neoplasms
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Lymphoma, Non-Hodgkin
6
Neuroblastoma
5
Leukemia, Biphenotypic, Acute
5
Myeloproliferative Disorders
4
Graft vs Host Disease
4
Multiple Myeloma
3
Medulloblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia
3
Hodgkin Disease
3
Ganglioneuroblastoma
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory, with Excess of Blasts
2
Teratoma
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Pinealoma
1
Neurofibrosarcoma
1
Interventions
Vincristine
5
Etoposide
5
Carboplatin
5
Melphalan
3
Topotecan
2
Platinum Compounds
2
Drug Therapy
2
Cyclophosphamide
2
Cryotherapy
2
pembrolizumab
1
omburtamab I-131
1
abemaciclib
1
Wechsler Scales
1
Watchful Waiting
1
Thiotepa
1
Surveys and Questionnaires
1
Specimen Handling
1
Observation
1
Microscopy, Acoustic
1
Memory and Learning Tests
1
Magnetic Resonance Spectroscopy
1
Lasers, Semiconductor
1
Lasers
1
LY2940680
1
Hyperthermia, Induced
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eye Enucleation
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Retinoblastoma
×
Thiotepa
×
1 year
×
Clear all
NCT02870907
2026-01-07
RB SFCE 09
Institut Curie
Phase 2
Active not recruiting
195 enrolled